← Back to headlines
BrainStorm Cell Therapeutics and Traws Pharma Beat EPS
BrainStorm Cell Therapeutics reported a GAAP EPS of -$0.19, beating estimates by $0.17. Traws Pharma also surpassed expectations with a GAAP EPS of -$0.53, beating by $0.03, alongside $0M in revenue.
15 May, 21:27 — 15 May, 21:27
Sources
Showing 1 of 1 sources
